Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment

Lung cancer remains the leading cause of cancer deaths. Non-small cell lung cancer (NSCLC) is the most frequent subtype of lung cancer. Surgery, radiation, chemotherapy, immunotherapy, or molecularly targeted therapy is used to treat NSCLC. Nevertheless, many patients who accept surgery likely develop distant metastases or local recurrence. In recent years, targeted treatments and immunotherapy have achieved improvement at a breakneck pace. Therapy must be customized for each patient based on the specific medical condition, as well as other variables. It is critical to have an accurate NSCLC sub-classification for tailored treatment, according to the latest World Health Organization standards.

Automated summary

Lung cancer is the leading cause of cancer deaths, with non-small cell lung cancer being the most common subtype. Surgery, radiation, chemotherapy, immunotherapy, or targeted therapy can be used to treat NSCLC. Targeted treatments and immunotherapy have shown significant advancements in recent years. Tailored treatment based on specific medical conditions and other variables is crucial, according to the latest World Health Organization standards.